Omniscient Investment Point - Chapter 269



Only Noblemtl

269 ​​Separately, Together – 2

(1)

The magnetic bone contract went through without a hitch.

In fact, there could be no defect.

I spent quite a bit of time doing thorough due diligence.

‘phew…….’

But, it was the moment when I realized that acquiring a company was not that easy.

Meanwhile, the new CEO of Magnetic was Myung Joo-won.

Having been appointed CEO early on, he promised me and Hyun Ki-hyuk that he would get out of the red as soon as possible.

Hyun Ki-hyuk said to him,

“The real economy is the key, so I hope we don’t rush things too much.”

Of course, I added a few words too.

“The recent growth rate has been quite high, but there are also reports that economic growth will stagnate in the future along with a slowdown in private consumption. Technically, we could be entering a recession, so I hope you will operate while treading firmly.”

In reality, the Japanese economy was not that easy.

In recent years, the growth rate has been decent, so it seems that the previous government decided to liquidate zombie companies.

This year alone, the number of corporate bankruptcies has increased by 33%.

I confirmed this fact through the report from the previous day.

― The cold spell came after the end of the so-called “zero-zero” loan, an interest-free, unsecured loan that the Japanese government had introduced to support companies. It is possible that Magnetic was not spared from the blow and was put up for sale.

Then a plan came to my mind.

‘If you do well, you may have more opportunities to pick up in the future.’

However, I didn’t need to rush.

As Hyun Ki-hyuk and I mentioned earlier, we could not help but consider the high probability of a recession.

Above all, it was a problem that private consumption continued to show negative growth.

There is another structural problem as well.

It is a wage increase.

Now, Japan’s new cabinet has found that private consumption is declining and has launched policies to boost the economy by increasing individual spending.

Naturally, companies have to give something in return for government pressure, and Magnetic was no exception.

Moreover, given Magnetic’s current situation, the carrot of a wage increase was essential.

This is because restructuring occurred during the sale process.

Perhaps, the employees will expect it.

The Korean private equity fund that recently acquired Magnetic will initially pour money into it.

“That’s fortunate. Since our CEO Oh is investing, I think it will be a great help.”

“Yes, that’s right.”

Hyun Ki-hyuk and I expressed our gratitude to Seung-hoon Oh.

He promised to invest a whopping 20 billion won.

“No, no. Rather, I am grateful that you have allowed me to invest in a company with promising prospects.”

“I feel good that you think so. It means that young people have a bright vision for Magnetic. Hahahaha.”

With his characteristic hearty laugh, Hyun Ki-hyuk said goodbye to us.

To be exact, we sent Hyun Ki-hyuk away.

It’s true that we’re both busy, but he and I had separate things to do.

The matter came up through Seunghoon Oh’s question.

“Where do we go from here?”

“I should stop by Hinome Pharmaceutical first.”

“Wow, I can’t wait.”

“Hey, the higher the expectations, the greater the disappointment.”

I had lowered my expectations, but when I actually arrived at Hinome Pharmaceuticals, I was the first one to be shocked.

The reason is… … .

(2)

After I met Yuta Kimura, introduced Seunghoon Oh, and we greeted each other.

“I have something to tell you, sir.”

“Yes, what is it?”

Yuta Kimura, CEO of Hinome Pharmaceutical, continued speaking with a face full of confidence and enthusiasm.

“A while ago, we created a new drug development team in-house.”

“If it’s the New Testament… … ?”

“It was created naturally, to be exact.”

From what I’ve heard, it doesn’t seem like it was originally intended to be a new testament.

In other words, they hired a lot of clinical research personnel with the purpose of upgrading existing drugs and selling them, and they naturally discovered a candidate substance for kidney cancer.

“Surprisingly, it was Cordyceps sinensis.”

“Corderygosporum? Imported from Korea?”

“Yes, that’s right.”

This is it.

Dr. Kati’s pancreatic cancer candidate was extracted from silkworms, and this time, a kidney cancer candidate was discovered using Cordyceps sinensis made from silkworms?

“In fact, we always had a shortage of manpower in the past. However, recently, the company’s business has improved, and there are more applicants for clinical research positions, so we were able to discover a candidate substance for kidney cancer.”

“I understand that the company’s situation has improved, but why are there so many job seekers for clinical researchers? Is there any particular reason?”

“It seems like the effect of increasing the number of medical schools is starting to show. Recently, the number has increased to ten thousand.”

“ah…….”

It’s the effect of increasing the number of medical schools.

I was secretly jealous.

Not only do we see more doctors willing to treat people, but we also see a virtuous cycle in which this leads to an increase in the number of clinical researchers.

Did you read my expression?

He let out an embarrassed voice.

“I heard that Korea is always noisy about that issue.”

“Yes, but there are many complicated parts, so it seems like it will take more time to resolve. Furthermore, it is impossible to even dream of increasing the number of troops by more than 10,000, like in Japan.”

“I hope everything works out well.”

“Yes, me too. But please continue talking. Actually, I am someone who has studied quite a bit in the biopharmaceutical field.”

“Oh, yes, yes. I understand.”

Utah probably didn’t want to talk to me about anything professional.

That’s understandable, even just hearing about the preclinical stage gives the average person a headache.

But I studied a lot early on, with an eye on investments in the pharmaceutical and bio sectors.

Forte Bio and Dr. Katido, that’s why they invested boldly and achieved the success they have now.

“As you may remember, the Cordycepin content in Cordyceps sinensis imported from Daeil Farm is overwhelmingly higher than that of other Cordyceps sinensis.”

“Yes, I know that too.”

“Our research team discovered that when cordycepin is aged for a certain period of time, it undergoes a slight transformation. We even gave it a new name, Saikato.”

“So, can we assume that the preclinical stage was achieved by chance?”

“Yes, that’s right.”

“Are you going to go in right away?”

Yuta Kimura nods again.

At that moment, the number ‘±40’ engraved in my right eye began to sparkle.

Naturally, I encouraged him with a satisfied smile.

“Don’t worry about the money. Since it has come to this, why don’t you hire more clinical researchers when there are so many applicants?”

“Huh? Yes… … . Okay.”

Although he manages Hinome Pharmaceutical, the source of funds is our JTS Partners.

Although Hinome Pharmaceutical’s finances were improving, it could not invest excessive amounts of money in a new kidney cancer drug.

But when I promised a massive offensive, he looked bewildered for a moment before he couldn’t hide his joy.

‘It’s for me.’

The moment Utah nodded, passing the Phase 1 clinical trial of Saikato became my goal.

40 days. I really hope I get through this in order to live longer.

(3)

“What? Do you think the new drug clinical trial will go well this time too?”

As I was leaving Hinome Pharmaceuticals, Seunghoon Oh asked me a question with a strange look in his eyes.

“What else won’t work?”

“It’s not that. It’s just that the clinical trials that are said to be so difficult somehow feel like the places you invest in are the only ones that are succeeding.”

“So. Then it won’t work?”

“haha…….”

Oh Seung-hoon smiled awkwardly.

I know why he asked that question.

‘There is a law of certain proportions in luck, right?’

The global new drug clinical trial success rate is between 5% and 10%.

That means, out of a hundred trials, five to ten will succeed.

But I was particularly lucky.

That was also close to a jackpot.

Forte Bio had already passed phase 3 clinical trials in Korea, heralding the birth of a blockbuster new drug, and Dr. Carty was also cruising along, but the media was reporting every day that the first pancreatic cancer treatment might come out in the form of a fourth-generation anticancer drug.

What if the fourth-generation anticancer drug and the first pancreatic cancer treatment passes phase 3?

Naturally, it could become a blockbuster new drug of all time.

But you’re aiming for a blockbuster three times in a row?

If there is a god of luck, he wouldn’t have given me that much luck.

Oh Seung-hoon might have thought so.

‘That’s not necessarily true.’

God also punished me with terminal pancreatic cancer.

As I said this to myself, I thought of a hypothesis I had recently established while looking at both of my eyes.

I didn’t commit a crime, but I was given this punishment?

Could this be my special mission to work hard to save humanity from cancer?

“I don’t know about anything else, but you’re investing in Hinome Pharmaceuticals, right? With that money, you can gather more clinical researchers and put more emphasis on developing new drugs. Right?”

“Well, that’s true, but… … .”

“Furthermore, the fact that it is a candidate substance for kidney cancer is somewhat strange.”

“Huh? What does that mean?”

“What, don’t you remember? Red yeast.”

“omg……!”

Red yeast, which has been a topic of conversation in Japan with a negative connotation.

Dietary supplements containing it have been linked to kidney disease.

Coincidentally, the candidate substance discovered by Hinome Pharmaceutical was associated with kidney cancer.

“Wow, if this gets reported to the media, it might affect the sales of Cordyceps sinensis from Daeil Farm, right?”

“It’s a carrot.”

Oh Seung-hoon, who just realized it, opens his eyes wide and looks at me.

And a slightly raised thumb.

“When will your luck end?”

“Well. When I die?”

“Okay, I got it. Please live to be a hundred. I’ll eat lots of bean curds next to you.”

Yeah, I want to do that too.

I smiled as I answered inwardly once again.

(4)

The last place we stopped by today was the Japanese branch of JTS Partners.

There was a reason.

To meet the new branch manager who will be in charge of this place.

He is… … .

“Director Choi, no. President Choi, how is the air in Japan?”

“haha…….”

It was Choi Soo-ri.

In fact, I had a lot of concerns, but I decided to appoint him as the branch manager in Japan some time ago.

“I don’t know if I can do it well.”

“Hey, they said that in Seoul too, so of course they’ll do well. I trust CEO Choi.”

“I will do my best.”

“Enough with that cliche, let’s take a look at some other companies besides Hinome Pharmaceuticals and Magnetic.”

“Yes, haha… … .”

In fact, former branch manager Myung Joo-won used to consistently list and report on several companies to me.

Because the amount of money going into magnetics is so huge and we don’t know how much more will go into it in the future, we just held back a little.

However, I never thought of letting up on the reins in order to keep pace with Hyun Ki-hyeok’s ambitions, both separately and together.

‘I guess I’ll have to create a Japanese investment fund sooner or later.’

If possible, we should ‘Buy Japan’ with the money invested by all the people.